相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Demethyleneberberine attenuates concanavalin A-induced autoimmune hepatitis in mice through inhibition of NF-κB and MAPK signaling
Miao Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Influence of miR-101 on proliferation of liver cancer cells through the MAPK/ERK signaling pathway
Xuan Meng et al.
ONCOLOGY LETTERS (2020)
Bradykinin contributes to immune liver injury via B2R receptor-mediated pathways in trichloroethylene sensitized mice: A role in Kupffer cell activation
Jiaxiang Zhang et al.
TOXICOLOGY (2019)
Analysis of the Mitochondrial Membrane Potential Using the Cationic JC-1 Dye as a Sensitive Fluorescent Probe
Farzane Sivandzade et al.
BIO-PROTOCOL (2019)
Role of selective blocking of bradykinin B1 receptor in attenuating immune liver injury in trichloroethylene-sensitized mice
Jiaxiang Zhang et al.
CYTOKINE (2018)
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
Richard S. Finn et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Oncogenic Signal and Tumor Microenvironment in Hepatocellular Carcinoma
Naoshi Nishida et al.
ONCOLOGY (2017)
The diagnosis and treatment of hepatocellular carcinoma
Justin Hartke et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2017)
Plasma Kallikrein-Kinin system mediates immune-mediated renal injury in trichloroethylene-sensitized mice
Hui Wang et al.
JOURNAL OF IMMUNOTOXICOLOGY (2016)
Targeted Therapy for Hepatocellular Carcinoma
Nitin Ohri et al.
SEMINARS IN RADIATION ONCOLOGY (2016)
Bradykinin antagonists and thiazolidinone derivatives as new potential anti-cancer compounds
Stanislav Avdieiev et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
The role of kinin receptors in cancer and therapeutic opportunities
Patricia L. N. da Costa et al.
CANCER LETTERS (2014)
Discovery and therapeutic potential of kinin receptor antagonists
Eric T. Whalley et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
From Bradykinin B2 Receptor Antagonists to Orally Active and Selective Bradykinin B1 Receptor Antagonists
Martine Barth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry
A. Perelman et al.
CELL DEATH & DISEASE (2012)
Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Jie Shi et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Strong cytotoxic effect of the bradykinin antagonist BKM-570 in ovarian cancer cells - analysis of the molecular mechanisms of its antiproliferative action
Stephanie Jutras et al.
FEBS JOURNAL (2010)
Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors
F. Kuhr et al.
NEUROPEPTIDES (2010)
Participation of kallikrein-kinin system in different pathologies
Claudio M. Costa-Neto et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection
Yubo Yang et al.
SURGERY (2007)
Activation of kinin B1 receptors induces chemotaxis of human neutrophils
P. Ehrenfeld et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Combination cancer chemotherapy with one compound: Pluripotent bradykinin antagonists
JM Stewart et al.
PEPTIDES (2005)
Kinin B1 receptors:: key G-protein-coupled receptors and their role in inflammatory and painful processes
JB Calixto et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Bradykinin-related compounds as new drugs for cancer and inflammation
JM Stewart et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2002)
Regulation of MAP kinase activity by peptide receptor signalling pathway: Paradigms of multiplicity
C Liebmann
CELLULAR SIGNALLING (2001)
分享论文
